Small rat islets are superior to large islets in in vitro function and in transplantation outcomes.
Barriers to the use of islet transplantation as a practical treatment for diabetes include the limited number of available donor pancreata. This project was designed to determine whether the size of the islet could influence the success rate of islet transplantations in rats. Islets from adult rats were divided into two groups containing small (diameter <125 microm) or large (diameter >150 microm) islets. An average pancreas yielded three times more small islets than large. Smaller islets were approximately 20% more viable, with large islets containing a scattered pattern of necrotic and apoptotic cells or central core cell death. Small islets in culture consumed twice as much oxygen as large islets when normalized for the same islet equivalents. In static incubation, small islets released three times more insulin under basal conditions than did large islets. During exposure to high glucose conditions, the small islets released four times more insulin than the same islet equivalencies of large islets, and five times more insulin was released by the small islets in response to glucose and depolarization with K+. Most importantly, the small islets were far superior to large islets when transplanted into diabetic animals. When marginal islet equivalencies were used for renal subcapsular transplantation, large islets failed to produce euglycemia in any recipient rats, whereas small islets were successful 80% of the time. The results indicate that small islets are superior to large islets in in vitro testing and for transplantation into the kidney capsule of diabetic rats.
MacGregor
R R
RR
Dept. of Physical Therapy and Rehabilitation Sciences, Univ. of Kansas Medical Center, 3901 Rainbow Blvd., Kansas City, KS 66160, USA.
Williams
S J
SJ
Tong
P Y
PY
Kover
K
K
Moore
W V
WV
Stehno-Bittel
L
L
D000818:Animals; D017209:Apoptosis; D001786:Blood Glucose / Q000378:metabolism; D002470:Cell Survival; D003921:Diabetes Mellitus, Experimental / Q000503:physiopathology / Q000601:surgery*; D050416:Glucagon-Secreting Cells / Q000166:cytology; D005947:Glucose / Q000494:pharmacology; D066298:In Vitro Techniques; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D050417:Insulin-Secreting Cells / Q000166:cytology; D007515:Islets of Langerhans / Q000033:anatomy & histology / Q000187:drug effects / Q000502:physiology*; D016381:Islets of Langerhans Transplantation; D008297:Male; D009336:Necrosis; D010101:Oxygen Consumption / Q000502:physiology; D011188:Potassium / Q000494:pharmacology; D051381:Rats; D016896:Treatment Outcome
D001786:Blood Glucose; D007328:Insulin; D005947:Glucose; D011188:Potassium